Kvutzat Acro Stock Revenue
| ACRO Stock | 5,527 154.00 2.87% |
Kvutzat Acro fundamentals help investors to digest information that contributes to Kvutzat Acro's financial success or failures. It also enables traders to predict the movement of Kvutzat Stock. The fundamental analysis module provides a way to measure Kvutzat Acro's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kvutzat Acro stock.
Kvutzat |
Kvutzat Acro Company Revenue Analysis
Kvutzat Acro's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Kvutzat Acro reported 0.0 of revenue. This is 100.0% lower than that of the Real Estate sector and about the same as Real Estate-Development (which currently averages 0.0) industry. The revenue for all Israel stocks is 100.0% higher than that of the company.
Kvutzat Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kvutzat Acro's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kvutzat Acro could also be used in its relative valuation, which is a method of valuing Kvutzat Acro by comparing valuation metrics of similar companies.Kvutzat Acro is currently under evaluation in revenue category among its peers.
Kvutzat Fundamentals
| Current Valuation | 4.52 B | |||
| Shares Outstanding | 57.51 M | |||
| Shares Owned By Insiders | 62.81 % | |||
| Shares Owned By Institutions | 14.85 % | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 5.80 X | |||
| Book Value Per Share | 27.61 X | |||
| Earnings Per Share | 1.96 X | |||
| Market Capitalization | 2.42 B | |||
| Annual Yield | 0.01 % |
About Kvutzat Acro Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kvutzat Acro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kvutzat Acro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kvutzat Acro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kvutzat Stock
Kvutzat Acro financial ratios help investors to determine whether Kvutzat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kvutzat with respect to the benefits of owning Kvutzat Acro security.